Cited by

• Validation of a Post-Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database.

  Lee CC, Hsu TC, Kuo CC, Liu MA, Abdelfattah AM, Chang CN, Yao M, Li CC, Wu KH, Chen TC, Gau JP, Wang PN, Liu YC, Chiou LW, Lee MY, Li SS, Chao TY, Jou ST, Chang HH. Lee CC, et al. Oncologist. 2021 Nov;26(11):e2034-e2041. doi: 10.1002/onco.13969. Epub 2021 Sep 23. Oncologist. 2021. PMID: 34506688 Free PMC article.
• Pediatric solid-organ transplant recipients carry chronic loads of Epstein-Barr virus exclusively in the immunoglobulin D-negative B-cell compartment.

  Rose C, Green M, Webber S, Ellis D, Reyes J, Rowe D. Rose C, et al. J Clin Microbiol. 2001 Apr;39(4):1407-15. doi: 10.1128/JCM.39.4.1407-1415.2001. J Clin Microbiol. 2001. PMID: 11283064 Free PMC article.
• EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.

  Macedo C, Webber SA, Donnenberg AD, Popescu I, Hua Y, Green M, Rowe D, Smith L, Brooks MM, Metes D. Macedo C, et al. J Immunol. 2011 May 15;186(10):5854-62. doi: 10.4049/jimmunol.1001024. Epub 2011 Apr 1. J Immunol. 2011. PMID: 21460204 Free PMC article.
• Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting the development of posttransplantation lymphoproliferative disease.

  Ohga S, Kubo E, Nomura A, Takada H, Suga N, Ishii E, Suminoe A, Inamitsu T, Matsuzaki A, Kasuga N, Hara T. Ohga S, et al. Int J Hematol. 2001 Apr;73(3):323-6. doi: 10.1007/BF02981956. Int J Hematol. 2001. PMID: 11345197
• Double-step PCR assay to quantify Epstein-Barr viral load in peripheral blood.

  Bergallo M, Merlino C, Daniele R, Sinesi F, Fumagalli M, Ponzi AN, Cavallo R. Bergallo M, et al. Mol Biotechnol. 2004 Jul;27(3):187-96. doi: 10.1385/MB:27:3:187. Mol Biotechnol. 2004. PMID: 15247492 Clinical Trial.